Contract Pharma Manufacturing Solutions

  1. Are Your Supply Chains Resilient Enough To Roll With The Punches? 3/18/2025

    Discover how we can support your next project with a winning strategy encompassing safe, secure, and reliable supply chains to help you bring your therapy to patients.

  2. Development & Testing Services 3/23/2022

    Our team of experts believe in collaboration and customizing our services to assist our clients through the drug development process.

  3. Ready To Meet Your Complex OSD Needs, Seamlessly And Simply

    Explore an approach that accelerates your project through key milestones with a technology transfer process that ensures a fast start and process analytical technology that increases efficiency and reduces cost.

  4. Integrated Operations Produce Top-Tier Raw Materials

    An integrated supply chain, with transparency among sponsors and suppliers, ensures that regulatory starting materials (RSMs) are well characterized and free of impurities that can impact the final drug product.

  5. Cell Line Characterization Testing Package 8/7/2024

    We offer a comprehensive range of assays to ensure the quality and safety of your cell lines. Our expertise in timely characterization is unparalleled, making us the ideal partner for testing.

  6. Making The Complex, Simple.

    With a comprehensive range of OSD manufacturing and packaging formats, we tailor our solutions to provide the optimal balance of product customization, quality, and supply reliability.

  7. Development And Manufacturing Services 4/29/2021

    Adare Pharma Solutions is a leading specialty contract development and manufacturing organization (CDMO) and a leading global provider of advanced pharmaceutical technologies, formulation, development, and manufacturing.

  8. mAb/Recombinant Protein Lot Release Package 8/7/2024

    Our comprehensive testing package includes assays to detect adventitious agents, assess general characteristics, and ensure compliance with cGMP regulations.

  9. Advancing CRISPR-Based Therapeutic Development 5/15/2024

    A CDMO that manufactures nucleases at research and cGMP grades can eliminate the need for custom manufacturing runs, simplify the transition to clinical application, and reduce regulatory paperwork.

  10. Keep A Close Eye On Quality With Excipients For Drug Formulation 8/27/2025

    Developing ophthalmic drugs demands precision and compliance. Explore a specialized excipient portfolio that supports optimal formulation to enhance stability, sterility, and patient comfort.